ENCHANNEL MEDICAL RAISES $82.2M IN OVERSUBSCRIBED SERIES-B FINANCING TO ADVANCE FULL-CHAMBER 5D ATRIAL FIBRILLATION MAPPING AND PERSONALIZED PULSED-FIELD ABLATION THERAPY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.